REMEDUS
ActiveREMEDUS has been active since 1995 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €463k and a net result of €736k. Equity is shrinking by ~14.7% per year across the filed fiscal years. Its solvency ranks better than 17% of 633 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability65▲+14
Solvency16▲+1
Growth56▲+17
Stability100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity short (current ratio 0.87 against 0.9 in 2024), and 89.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
10.9%
Return on assets
17.3%
Age of the figures
9 mo
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 633 sector peers (2025).
NBB · sector comparisonPosition among 633 sector peers
Solvency
better than 17%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 d early
2024
105 d late
2023
155 d late
2022
301 d late
2021
19 d early
2021
40 d early
2020
114 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
16-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
€16.70M▲ 6.2%
2024 · €15.73M
2019: €11.33M
2020: €11.32M
2021: €11.90M
2021: €6.27M
2022: €12.99M
2023: €14.23M
2024: €15.73M
2019 → 2025
EBIT margin
6.6%▲ 5.2pp
2024 · 1.4%
2019: 5.8%
2020: 3.1%
2021: 2.7%
2021: 24.3%
2022: 16.1%
2023: 4.8%
2024: 1.4%
2019 → 2025
Net result
€736k▲ 424%
2024 · €141k
2019: €644k
2020: €346k
2021: €311k
2021: €1.47M
2022: €1.64M
2023: €539k
2024: €141k
2019 → 2025
Working capital
€-461k▲ 1.1%
2024 · €-466k
2019: €525k
2020: €649k
2021: €-260k
2021: €-267k
2022: €510k
2023: €507
2024: €-466k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€6.27M-€12.99M▲ 107%€14.23M▲ 9.6%€15.73M▲ 10.5%€16.70M▲ 6.2%
Equity€506k-€1.45M▲ 186%€1.19M▼ 18.0%€527k▼ 55.6%€463k▼ 12.1%
Operating result€1.53M-€2.09M▲ 37.2%€684k▼ 67.3%€223k▼ 67.4%€1.10M▲ 395%
Net result€1.47M-€1.64M▲ 11.4%€539k▼ 67.2%€141k▼ 73.9%€736k▲ 424%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 395% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €4.25M
Fixed assets
€1.02M▼ 24.1%
Current assets
€3.23M▼ 19.2%
Equity and liabilities €4.25M
Equity
€463k▼ 12.1%
Debt
€3.78M▼ 21.3%
The debt ratio falls from 90.1% to 89.1%: debt falls faster than equity shrinks.
Key figures and ratios
EBITDA
€1.62M▲
2024 · €769k
Cash flow
€1.25M▲
2024 · €687k
Solvency
10.9%▲
2024 · 9.9%
Current ratio
0.87▼
2024 · 0.90
Quick ratio
0.72▼
2024 · 0.79
Debt / equity
8.17▼
2024 · 9.13
ROE
158.9%▲
2024 · 26.7%
ROA
17.3%▲
2024 · 2.6%
Interest coverage
99.38▲
2024 · 83.73
Debt
€3.78M▼
2024 · €4.81M
Debt ≤ 1 year
€3.69M▼
2024 · €4.46M
Income taxes
€348k▲
2024 · €70k
Staff costs
€5.24M▲
2024 · €4.68M
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€5.34M€4.25M▼
Fixed assets21/28€1.35M€1.02M▼
Intangible fixed assets21€326k€192k▼
Tangible fixed assets22/27€1.02M€830k▼
Plant, machinery and equipment23€762k€622k▼
Furniture and vehicles24€76k€45k▼
Other tangible fixed assets26€182k€162k▼
Assets under construction and advance payments27€0-
Financial fixed assets28€0-
Other financial fixed assets284/8€0-
Amounts receivable and cash guarantees285/8€0-
Current assets29/58€3.99M€3.23M▼
Stocks and contracts in progress3€457k€587k▲
Stocks30/36€457k€587k▲
Goods purchased for resale34€457k€587k▲
Amounts receivable within one year40/41€1.97M€2.14M▲
Trade receivables40€1.81M€2.14M▲
Other amounts receivable41€157k€0▼
Cash at bank and in hand54/58€1.52M€437k▼
Deferred charges and accrued income490/1€41k€63k▲
Equity and liabilities
Total equity and liabilities10/49€5.34M€4.25M▼
Equity10/15€527k€463k▼
Contributions10/11€19k€19k=
Reserves13€29k€29k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Tax-exempt reserves132€27k€27k=
Profit (loss) carried forward14€480k€416k▼
Amounts payable17/49€4.81M€3.78M▼
Amounts payable within one year42/48€4.46M€3.69M▼
Trade debts44€1.84M€2.01M▲
Suppliers440/4€1.84M€2.01M▲
Taxes, remuneration and social security45€850k€698k▼
Taxes450/3€135k€152k▲
Remuneration and social security454/9€715k€546k▼
Other amounts payable47/48€1.77M€980k▼
Accrued charges and deferred income492/3€353k€98k▼
Income statement
Code20242025
Operating income70/76A€15.76M€17.39M▲
Turnover70€15.73M€16.70M▲
Other operating income74€32k€692k▲
Non-recurring operating income76A€145€1▼
Operating charges60/66A€15.53M€16.29M▲
Goods for resale, raw materials and consumables60€6.19M€6.47M▲
Purchases600/8€6.14M€6.61M▲
Change in stocks: decrease (increase)609€43k€-131k▼
Services and other goods61€4.03M€3.91M▼
Remuneration, social security and pensions62€4.68M€5.24M▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€546k€518k▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€79k€113k▲
Other operating charges640/8€10k€29k▲
Operating profit (loss)9901€223k€1.10M▲
Financial income75/76B€294€0▼
Recurring financial income75€294€0▼
Other financial income752/9€294€0▼
Financial charges65/66B€12k€19k▲
Recurring financial charges65€12k€19k▲
Debt charges650€9k€16k▲
Other financial charges652/9€3k€3k▲
Profit (loss) for the period before taxes9903€211k€1.08M▲
Income taxes67/77€70k€348k▲
Taxes670/3€70k€348k▲
Profit (loss) for the period9904€141k€736k▲
Profit (loss) for the period to be appropriated9905€141k€736k▲
Appropriation of the result
Profit (loss) to be appropriated9906€1.28M€1.22M▼
Profit (loss) brought forward from the previous period14P€1.14M€480k▼
Profit to be distributed694/7€800k€800k=
Return on contributions (dividend)694€800k€800k=
Social balance
Average headcount (FTE)908760.864.6▲
The notes to these accounts (51 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
13-11
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 105 days late
02-01
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 155 days late
2024
31-12
Financial
Weakest financial yearnet €141k ▼73.9%
Net result drops to €141k, the lowest in the series; recovery starts the following year.
27-05
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 301 days late
2022
31-12
Financial
Highest result since 2019net €1.64M ▲11.4%
Operating result €2.09M, net result €1.64M, both a record.
31-12
Financial
Equity above €1MEq €1.45M ▲186%
5 profitable years in a row build equity to €1.45M.
12-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
22-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
25-05
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 114 days late
2020
21-01
NBB filing
Annual accounts filed
fiscal year 2019 · full schema
2019
10-01
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
12-01
NBB filing
Annual accounts filed
fiscal year 2017 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2024
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
01-08-2024
Rudi Van Bever: Resigned as Director
30-09-2021
CUR@DOMUM: Resigned as Director
30-09-2021
REMEDIA: Resigned as Director
30-09-2021
REMEDUS PHARMA: Resigned as Director
01-09-2016
Lexocon BVBA: Resigned as Manager
Location & real-estate footprint
Registered office, Kontich · 1 establishment unit since 1996
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Satenrozen 192550 KontichGround area
435 m²
Parcel 11024G0007/00E000, Flanders. Linked by address, not a title deed.
1 establishment unit
REMEDUS
since 19962.074.564.041
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11024G0007/00E000 | Flanders | 435 m² | - | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 to 2025 · 7 entries · 19,742 EUR awarded · 19,741 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 3,395 EUR | 5,203 EUR |
| 2024 | 2 | 1,809 EUR | 140 EUR |
| 2023 | 2 | 3,639 EUR | 7,835 EUR |
| 2022 | 2 | 10,899 EUR | 6,563 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Vlaams opleidingsverlof (VOV)
Subsidies jeugdhulp
Recognitions · licences · registrations
Food safety, FASFC
1 siteKontich2.074.564.041
Legal Entity Identifier
699400SDKA06H54K0G76
Similar companies · same sector, comparable size
GHE.VET.CO
BE 0877.114.481
Wevelgem · Eq €463k
ESCOS
BE 0472.961.310
Tubize · Eq €465k
MEDICAL CARE SYSTEMS
BE 0443.747.482
Gingelom · Eq €467k
Adler Ortho Belgium
BE 0875.339.282
Brussel · Eq €459k
COLE PHARMACEUTICALS
BE 0671.904.152
Mont-Saint-Guibert · Eq €468k
Of 1,893 companies in sector 46460 we hold annual accounts for 1,113. 765 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-12-1995
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
85146
86909Human health activities
86995Nutrition and dietetics services
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
52320
Sources
Crossroads Bank for EnterprisesNational Bank · 29 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.